La vendita allo scoperto per Protagenic Therapeutics dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Protagenic Therapeutics. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Protagenic Therapeutics (NASDAQ:PTIX) Azioni, Report sulle vendite allo scoperto

Protagenic Therapeutics

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

<h3>Gainers</h3>
<ul>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock rose 45.4% to $0.39 during Wednesday's pre-market session. The company's market cap stands at $57.7 million. </li>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) shares moved upwards by 42.5% to $0.18. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>Kindly MD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) stock moved upwards by 33.67% to $20.35. The company's market cap stands at $122.5 million. </li>
<li>Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) shares moved upwards by 22.64% to $1.3. The company's market cap stands at $64.8 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares moved upwards by 19.23% to $0.01. </li>
<li>Immuron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRN#NASDAQ">IMRN</a>) stock moved upwards by 12.11% to $1.8. The market value of their outstanding shares is at $10.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>INVO Fertility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVF#NASDAQ">IVF</a>) shares declined by 12.7% to $1.9 during Wednesday's pre-market session. The company's market cap stands at $9.3 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Editas Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) stock declined by 11.75% to $1.45. The company's market cap stands at $121.1 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares decreased by 9.16% to $6.25. The company's market cap stands at $3.6 million. </li>
<li>Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) shares decreased by 9.06% to $3.0. The market value of their outstanding shares is at $417.1 million. </li>
<li>HeartBeam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>) shares fell 9.04% to $1.51. The market value of their outstanding shares is at $51.0 million. </li>
<li>Akso Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHG#NASDAQ">AHG</a>) shares declined by 8.13% to $1.52. The company's market cap stands at $606.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AKYA

BDSX

BEAT

EDIT

IMRN

KDLY

PLRZ

PTIX

PTPI

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock moved upwards by 2412.3% to $5.12 during Tuesday's regular session. The company's market cap stands at $466.1 million. The company's, Q2 earnings came out 3 days ago. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) stock increased by 42.47% to $1.61. The company's market cap stands at $4.5 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>bioAffinity Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) stock moved upwards by 23.28% to $0.28. The company's market cap stands at $5.0 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares increased by 22.5% to $431.22. The market value of their outstanding shares is at $5.6 billion. </li>
<li>Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) stock rose 18.79% to $1.68. The market value of their outstanding shares is at $307.3 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) shares increased by 17.2% to $1.35. The company's market cap stands at $53.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) stock fell 31.1% to $7.65 during Tuesday's regular session. The market value of their outstanding shares is at $4.5 million. </li>
<li>DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) shares decreased by 17.74% to $8.88. The company's market cap stands at $243.0 million. </li>
<li>Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) shares fell 15.14% to $0.28. The company's market cap stands at $8.1 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares decreased by 13.64% to $0.01. </li>
<li>Anavex Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) shares declined by 12.62% to $7.38. The company's market cap stands at $629.6 million. </li>
<li>Alumis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMS#NASDAQ">ALMS</a>) shares declined by 11.85% to $5.25. The company's market cap stands at $285.3 million. The company's, Q1 earnings came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALMS

AVXL

BIAF

DBVT

EKSO

EYEN

TELA

12 Health Care Stocks Moving In Tuesday's Intraday Session

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.17% to 42,717.49 while the NASDAQ fell 0.60% to 19,100.94. The S&amp;P 500 also fell, dropping, 0.28% to 5,946.87.
Check This Out: <a href="https://www.benzinga.com/25/05/45516277/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 4% Dividend Yields</a>
Leading and Lagging Sectors Utilities shares rose by 0.4% on Tuesday.
In trading on Tuesday, information technology stocks dipped by 1.1%.
Top Headline
Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) reporting better-than-expected first-quarter sales results and reaffirmed its full-year outlook.
Sales rose 9.4% year over year to $39.86 billion, topping the $39.33 billion consensus. Adjusted earnings per share fell 3% to $3.56, missing the $3.60 estimate.
Home Depot reaffirmed it forecast of total sales growth of 2.8% year-over-year, reaching $163.98 billion, below the consensus of $164.17 billion. The company anticipates adjusted earnings per share will decline about 2% to $14.94, lower than the $14.99 consensus estimate.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares shot up 255% to $0.3682.</li>
<li>Shares of NeurAxis, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRXS#NYSE">NRXS</a>) got a boost, surging 117% to $4.92 after the company announced it received FDA 510(K) clearance regarding IB-stim for the treatment of pediatric FAP associated with functional dyspepsia and FD related nausea symptoms.</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares were also up, gaining 39% to $5.64.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares dropped 23% to $0.2626 after the company reported quarterly results for the three months ended March 31.</li>
<li>Shares of Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) were down 22% to $0.2578 after the company announced a 1-for-15 reverse stock split to regain Nasdaq compliance.</li>
<li>Protagenic Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) was down, falling 18% to $9.15. Protagenic Therapeutics recently entered a business combination with Phytanix.</li>
</ul>
Commodities In commodity news, oil traded down 0.6% to $62.30 while gold traded up 0.4% at $3,245.80.
Silver traded up 0.4% to $32.625 on Tuesday, while copper fell 1% to $4.6225.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.8%, while Spain's IBEX 35 Index rose 1.7%. London's FTSE 100 rose 0.9%, Germany's DAX 40 gained 0.6% and France's CAC 40 climbed 0.9% during the session.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan's Nikkei gaining 0.08%, Hong Kong's Hang Seng Index gaining 1.49%, China's Shanghai Composite Index rising 0.38% and India's BSE Sensex declining 1.06%.
Economics
US Redbook Index rose by 5.4% year-over-year in the week ending May 17.
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45517457/spotify-to-rally-more-than-16-here-are-10-top-analyst-forecasts-for-tuesday">Spotify To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

BLMZ

MULN

NRXS

SYTA

Nasdaq Falls 100 Points; Home Depot Sales Top Views

<h3>Gainers</h3>
<ul>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares moved upwards by 56.6% to $1.77 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.0 million. The company's, Q1 earnings came out yesterday. </li>
<li>Instil Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) shares increased by 30.17% to $22.0. The company's market cap stands at $144.3 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock increased by 27.47% to $0.01. </li>
<li>Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) stock moved upwards by 25.23% to $1.34. The market value of their outstanding shares is at $22.2 million. </li>
<li>bioAffinity Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) stock rose 24.84% to $0.28. The market value of their outstanding shares is at $5.1 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock increased by 14.48% to $403.0. The company's market cap stands at $5.2 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) stock fell 20.7% to $8.8 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.1 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares fell 19.6% to $0.33. The company's market cap stands at $1.5 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) stock decreased by 18.16% to $0.27. The company's market cap stands at $7.8 million. </li>
<li>Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) stock decreased by 13.1% to $0.09. The company's market cap stands at $6.1 million. </li>
<li>Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) stock decreased by 11.03% to $1.21. The company's market cap stands at $6.9 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) stock declined by 10.45% to $0.3. The market value of their outstanding shares is at $1.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BCLI

ENTO

HCTI

IRIX

LYRA

PSTV

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Shares of Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) rose sharply in today's pre-market after it was announced that the company will join the <a href="https://www.benzinga.com/quote/PEGA">S&amp;P Midcap 400</a>.
Pegasystems will replace Nordstrom in the S&amp;P Midcap 400 effective prior to the opening of trading on May 22.
Pegasystems shares jumped 6.5% to $104.86 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) rose 100% to $0.2023 in pre-market trading.</li>
<li>Eyenovia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) surged 44.2% to $1.63 in pre-market trading after the company provided an update on its merger with Betaliq. The company also reported better-than-expected first-quarter EPS results.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) gained 36.1% to $0.3075 in pre-market trading after gaining 6% on Monday.</li>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) jumped 30.7% to $0.0119 in pre-market trading after surging 15% on Monday.</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) surged 25.3% to $5.10 in pre-market trading after jumping over 76% on Monday.</li>
<li>Incannex Healthcare Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>) gained 21% to $0.2419 in pre-market trading after dipping 23% on Monday. Incannex Healthcare, last week, reported a year-over-year increase in third-quarter EPS results.</li>
<li>Instil Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) climbed 18.7% to $20.06 in pre-market trading after gaining over 15% on Monday.</li>
<li>ASP Isotopes Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPI#NASDAQ">ASPI</a>) gained 14.4% to $8.60 in pre-market trading after the company announced it has entered into a loan and supply agreement with TerraPower to support construction of new HALEU uranium enrichment facility in South Africa.</li>
<li>X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) rose 9.7% to $16.45 in pre-market trading after reporting first-quarter results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Lyra Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) shares fell 20.2% to $0.0853 in pre-market trading after declining over 4% on Monday.</li>
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) fell 18.4% to $0.2775 in pre-market trading after jumping 100% on Monday.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) fell 17.6% to $9.15 in today's pre-market trading. Protagenic Therapeutics shares jumped 266% on Monday after the company entered a business combination with Phytanix.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) fell 16.9% to $0.2750 in pre-market trading after the company reported a 1-for-15 reverse stock split.</li>
<li>DigiAsia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) shares dipped 15.6% to $0.30 in pre-market trading. DigiAsia announced the launch of Bitcoin treasury reserve strategy. The company said it is exploring up to $100 million capital raise to acquire Bitcoin.</li>
<li>Aspire Biopharma Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) shares tumbled 12% to $0.2201 in pre-market trading.</li>
<li>AIFU Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFU#NASDAQ">AIFU</a>) shares fell 11.7% to $0.1565 in pre-market trading.</li>
<li>Ruanyun Edai Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) dipped 11.2% to $11.00 in pre-market trading after gaining around 23% on Monday.</li>
<li>Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) declined 8.2% to $14.20 in pre-market trading following first-quarter earnings.</li>
<li>Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) fell 5% to $17.21 in pre-market trading. Asana will release financial results for the first quarter fiscal year 2026 on Tuesday, June 3, after the closing bell.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45492092/jim-cramer-was-skeptical-of-rocket-lab-now-says-its-actually-a-decent-story">Jim Cramer Was &#8216;Skeptical&#8217; Of Rocket Lab, Now Says &#8216;It&#8217;s Actually A Decent Story&#8217;</a> </li>
</ul>
Photo via Shutterstock

AIFU

ASAN

ASBP

ASPI

FAAS

IXHL

PEGA

RYET

VIPS

Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Monday.
The Dow traded up 0.40% to 42,825.71 while the NASDAQ rose 0.02% to 19,215.06. The S&amp;P 500 also rose, gaining, 0.13% to 5,965.84.
Check This Out: <a href="https://www.benzinga.com/25/05/45489465/top-3-tech-and-telecom-stocks-that-may-rocket-higher-this-month">Top 3 Tech And Telecom Stocks That May Rocket Higher This Month</a>
Leading and Lagging Sectors Consumer staples shares rose by 0.1% on Monday.
In trading on Monday, energy stocks dipped by 1.5%.
Top Headline
Global Ship Lease, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) reported upbeat results for the first quarter on Monday.
The company posted quarterly earnings of $2.65 per share which beat the analyst consensus estimate of $2.31 per share. The company reported quarterly sales of $190.97 million which beat the analyst consensus estimate of $175.23 million.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>DigiAsia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) shares shot up 188% to $0.5351 after the company announced the launch of Bitcoin treasury reserve strategy. The company said it is exploring up to $100 million capital raise to acquire Bitcoin.</li>
<li>Shares of Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) got a boost, surging 163% to $7.96 after the company entered a business combination with Phytanix</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares were also up, gaining 8% to $7.29 after the company provided FY25, 2026, and 2027 R&amp;D and SG&amp;A expense guidance. The FDA gave its conditional approval to its COVID-19 vaccine, targeting specific populations under particular conditions.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Gilat Satellite Networks Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILT#NASDAQ">GILT</a>) shares dropped 9% to $6.08 after the company reported a first-quarter revenue miss.</li>
<li>Shares of Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) were down 10% to $11.64. Quantum Computing, last week, reported better-than-expected first-quarter EPS results.</li>
<li>Archer Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) was down, falling 10% to $12.01.</li>
</ul>
Commodities In commodity news, oil traded up 0.1% to $62.51 while gold traded up 1.4% at $3,233.
Silver traded up 0.2% to $32.410 on Monday, while copper rose 1% to $4.6390.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.20%, while Spain's IBEX 35 Index rose 0.06%. London's FTSE 100 fell 0.14%, Germany's DAX 40 gained 0.28% and France's CAC 40 slipped 0.30% during the session.
Asia Pacific Markets
Asian markets closed mostly lower on Monday, with Japan's Nikkei falling 0.68%, Hong Kong's Hang Seng Index declining 0.05%, China's Shanghai Composite Index falling 0.004% and India's BSE Sensex declining 0.33%.
Economics
The CB Leading Index fell 1% month-over-month in April.
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

ACHR

GILT

NVAX

QUBT

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

<h3>Gainers</h3>
<ul>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares rose 286.8% to $11.72 during Monday's regular session. The company's market cap stands at $6.3 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock increased by 56.96% to $0.01. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares increased by 30.83% to $1.57. The market value of their outstanding shares is at $21.6 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) shares rose 27.17% to $0.29. The market value of their outstanding shares is at $15.2 million. </li>
<li>Tango Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>) shares increased by 23.2% to $1.85. The company's market cap stands at $200.3 million. </li>
<li>Novavax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) stock moved upwards by 20.8% to $8.13. The market value of their outstanding shares is at $1.3 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Prime Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) stock fell 19.2% to $1.28 during Monday's regular session. The company's market cap stands at $168.7 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares fell 16.67% to $0.35. The company's market cap stands at $2.0 million. </li>
<li>Applied Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) stock fell 15.4% to $0.51. The market value of their outstanding shares is at $72.2 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>Matinas BioPharma Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#AMEX">MTNB</a>) shares decreased by 13.53% to $0.75. The market value of their outstanding shares is at $3.8 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares decreased by 12.81% to $342.68. The market value of their outstanding shares is at $4.4 billion. </li>
<li>Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) stock declined by 11.1% to $16.79. The market value of their outstanding shares is at $1.4 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLT

LQDA

MTNB

PRME

SXTC

TNGX

12 Health Care Stocks Moving In Monday's Intraday Session

Shares of Protagenic Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) surged 306% to $12.32 Monday morning following news of a definitive all-stock <a href="https://www.benzinga.com/pressreleases/25/05/ac45490560/protagenic-therapeutics-and-phytanix-announce-business-combination-to-form-neuroactive-biopharmac">merger agreement</a> with Phytanix Bio.
What To Know: The combined company, to be named Phytanix, will focus on treatments for central nervous system and stress-related disorders, boasting five preclinical assets and one clinical-stage peptide (PT-00114) already in the BLA pathway.
Phytanix's pipeline includes PHYX-001, a potassium channel modulator akin to XEN1101, and cannabinoid- and stilbenoid-based compounds targeting CNS, cardiometabolic, and anticonvulsant indications. 
Under the deal, Phytanix shareholders received a mix of Protagenic common and preferred shares, plus warrants, in exchange for their equity. Post-merger, Phytanix shareholders will own 65% of the combined entity on a fully diluted basis.
The transaction closed May 16, with share conversions subject to Nasdaq stockholder approval.
Read Also: <a href="https://www.benzinga.com/general/space/25/05/45493132/whats-going-on-with-virgin-galactic-stock">What&#8217;s Going On With Virgin Galactic Stock?</a>
<h2 class="wp-block-heading">How To Buy PTIX Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Protagenic Therapeutics&#8217; case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, PTIX has a 52-week high of $26.18 and a 52-week low of $2.35.

Protagenic Therapeutics (PTIX) Stock Soars 240% On Phytanix Merger

Protagenic Therapeutics Shares Resume Trade

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Monday.
Following the market opening Monday, the Dow traded down 0.48% to 42,450.71 while the NASDAQ fell 0.88% to 19,041.91. The S&amp;P 500 also fell, dropping, 0.79% to 5,911.48.
Check This Out: <a href="https://www.benzinga.com/25/05/45489465/top-3-tech-and-telecom-stocks-that-may-rocket-higher-this-month">Top 3 Tech And Telecom Stocks That May Rocket Higher This Month</a>
Leading and Lagging Sectors Health care shares slipped by just 0.2% on Monday.
In trading on Monday, energy stocks dipped by 2.2%.
Top Headline
ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) reported better-than-expected earnings for the first quarter.
The company posted quarterly earnings of $2.45 per share which beat the analyst consensus estimate of $1.87 per share. The company reported quarterly sales of $2.01 billion which beat the analyst consensus estimate of $1.85 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>DigiAsia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) shares shot up 209% to $0.5739 after the company announced the launch of Bitcoin treasury reserve strategy. The company said it is exploring up to $100 million capital raise to acquire Bitcoin.</li>
<li>Shares of Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) got a boost, surging 164% to $8.00 after the company entered a business combination with Phytanix</li>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares were also up, gaining 79% to $0.0141.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Damon Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) shares dropped 62% to $0.0029.</li>
<li>Shares of Affimed N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) were down 34% to $0.1833 after jumping 228% on Friday.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) was down, falling 35% to $0.1869.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $62.20 while gold traded up 1.4% at $3,233.10.
Silver traded up 0.3% to $32.465 on Monday, while copper rose 1.1% to $4.6460.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.4%, while Spain's IBEX 35 Index fell 0.1%. London's FTSE 100 fell 0.5%, Germany's DAX 40 slipped 0.1% and France's CAC 40 slipped 0.7% during the session.
Asia Pacific Markets
Asian markets closed mostly lower on Monday, with Japan's Nikkei falling 0.68%, Hong Kong's Hang Seng Index declining 0.05%, China's Shanghai Composite Index falling 0.004% and India's BSE Sensex declining 0.33%.
Economics
The CB Leading Index will be released today.
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45490061/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-6">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a> </li>
</ul>
Photo via Shutterstock

AFMD

ZAPP

Dow Tumbles 200 Points; ZIM Integrated Shipping Services Posts Upbeat Earnings

<h3>Gainers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock increased by 110.1% to $0.02 during Monday's pre-market session. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) stock rose 78.48% to $5.41. The market value of their outstanding shares is at $2.9 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) stock rose 41.66% to $1.87. The company's market cap stands at $10.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock increased by 34.84% to $0.01. </li>
<li>Armata Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ARMP#AMEX">ARMP</a>) stock increased by 32.59% to $1.79. The company's market cap stands at $64.7 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares moved upwards by 25.04% to $1.5. The market value of their outstanding shares is at $20.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Mainz Biomed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNZ#NASDAQ">MYNZ</a>) shares decreased by 17.6% to $2.01 during Monday's pre-market session. The market value of their outstanding shares is at $4.4 million. </li>
<li>Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) stock fell 14.78% to $6.69. The market value of their outstanding shares is at $44.0 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>I-MAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) stock fell 11.12% to $0.8. The company's market cap stands at $64.7 million. The company's, H1 earnings came out 2 days ago. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares decreased by 10.51% to $4.09. The market value of their outstanding shares is at $22.4 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Lipocine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPCN#NASDAQ">LPCN</a>) stock fell 8.78% to $3.64. The market value of their outstanding shares is at $19.4 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock decreased by 7.89% to $0.21. The company's market cap stands at $5.8 million. As per the news, the Q1 earnings report came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARMP

FBRX

IMAB

KLTO

LPCN

MYNZ

STSS

12 Health Care Stocks Moving In Monday's Pre-Market Session

WIIM

Protagenic Therapeutics shares are trading higher after the company entered a business combination with Phytanix

Structure of Combination
Under the terms of the Exchange Agreement, the Company, in exchange for all of the outstanding shares of Phytanix Bio, issued on a pro rata basis to each of the common stockholders of Phytanix Bio, an aggregate of (A) 117,690 shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), which shares represent a number equal to no more than 19.99% of the outstanding shares of Common Stock as of immediately before the closing on May 16, 2025, (B) 5,705 shares of the Company's Series C Convertible Preferred Stock, par value $0.000001 per share (the "Series C"), and (C) 950,000 shares of the Company's Series C-1 Convertible Preferred Stock, par value $0.000001 per share (the "Series C-1"). In addition, in exchange for all of the outstanding preferred stock of Phytanix Bio, the Company issued on a pro rata basis to each of PHX's preferred stockholders an aggregate of (i) 20,000 shares of Series D Preferred Stock, par value $0.000001 per share of the Company (the "Series D" together with the Series C and Series C-1, the "Preferred Stock"), and (ii) common stock purchase warrants to purchase up to 715,493 shares of common stock (the "Warrants"). The issuance of the shares of Common Stock, the Preferred Stock, and the Warrants occurred on May 16, 2025. Each share of Preferred Stock is convertible into one of common stock, subject to certain conditions described in the Exchange Agreement.
As calculated on a fully diluted basis, post-Combination pre-financing ownership will be approximately 35% for the pre-Combination stockholders of the Company and approximately 65% for Phytanix Bio stockholders.
The issuance of shares of common stock upon conversion of the Preferred Stock and exercise of the Warrants issued in the Combination shall be subject to stockholder approval in compliance with the rules of the Nasdaq Stock Market.

As Calculated On A Fully Diluted Basis, Post-Combination Pre-Financing Ownership Will Be Approximately 35% For The Pre-Combination Stockholders Of The Company And Approximately 65% For Phytanix Bio Stockholders.

Protagenic Therapeutics And Phytanix Enter Business Combination In All-Stock Transaction

Shares of Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) rose sharply in today's pre-market after the company reported better-than-expected first-<a href="https://in.benzinga.com/news/earnings/25/05/45456393/quantum-computing-inc-reports-q1-earnings-shares-move-higher-after-hours">quarter EPS results</a>.
Quantum Computing reported first-quarter revenue of $39,000, missing analyst estimates of $100,000, according to Benzinga Pro. The company reported first-quarter earnings of 11 cents per share, beating estimates for a loss of seven cents per share.
Quantum Computing shares jumped 11.6% to $10.32 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) surged 56.7% to $13.90 in pre-market trading after the company reported a year-over-year increase in first-quarter revenue results.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) rose 51.1% to $2.75 in pre-market trading after the company reported third-quarter results.</li>
<li>Virgin Galactic Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NASDAQ">SPCE</a>) gained 29% to $4.32 in pre-market trading after the company reported better-than-expected first-quarter financial results.</li>
<li>Incannex Healthcare Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>) gained 28.8% to $0.3457 in pre-market trading after dipping 62% on Thursday. The company reported a year-over-year increase in third-quarter EPS results.</li>
<li>Kalaris Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLRS#NASDAQ">KLRS</a>) jumped 21.5% to $4.30 in pre-market trading after gaining around 5% on Thursday.</li>
<li>Biofrontera Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) surged 12.9% to $0.79 in pre-market trading after reporting first-quarter results.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) climbed 12.2% to $3.50 in pre-market trading after declining around 5% on Thursday. The company recently reported first-quarter financial results.</li>
<li>Satellogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) gained 9.2% to $5.09 in pre-market trading. On Tuesday, the company reported a year-over-year increase in first-quarter sales results.</li>
<li>The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) rose 6.3% to $67.70 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares fell 67.8% to $0.0121 in pre-market trading after dipping 83% on Thursday.</li>
<li>Origin Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGN#NASDAQ">ORGN</a>) fell 28.1% to $0.4655 in today's pre-market trading after the company reported a year-over-year decrease in first-quarter financial results and cut its FY26 sales guidance below estimates.</li>
<li>Globant S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) shares dipped 26.2% to $98.00 in pre-market trading after the company reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and cut its FY25 guidance.</li>
<li>LogProstyle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGPS#NASDAQ">LGPS</a>) fell 24.6% to $2.05 in pre-market trading after dipping 55% on Thursday.</li>
<li>Click Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares tumbled 26% to $0.5250 in pre-market trading. Click Holdings shares jumped 154% on Thursday after the company announced it signed a cooperation agreement with Flash Mutual Technology.</li>
<li>Abpro Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) shares fell 23.7% to $0.2022 in pre-market trading after gaining 60% on Thursday.</li>
<li>Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) dipped 22.1% to $45.52 in pre-market trading after the company issued FY26 sales guidance below estimates.</li>
<li>CISO Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) fell 21.3% to $0.9527 in pre-market trading after dipping 15% on Thursday.</li>
<li>Travere Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) declined 15.2% to $17.94 in pre-market trading. The company announced that the FDA accepted its supplemental New Drug Application for traditional approval of FILSPARI for the treatment of focal segmental glomerulosclerosis.</li>
<li>Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell 5.8% to $164.65 in pre-market trading. Applied Materials reported better-than-expected earnings for its second quarter, while sales missed estimates. Applied Materials said it expects third-quarter revenue of $7.2 billion, plus or minus $500 million, versus estimates of $7.19 billion. The company expects third-quarter adjusted earnings to be between $2.15 and $2.55 per share, versus estimates of $2.32 per share.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

AMAT

BFRI

CISO

CLIK

DOCS

GLOB

KLRS

LGPS

ORGN

SATL

SPCE

TSSI

TVTX

Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Protagenic Therapeutics shares are trading lower. The company reported Q1 financial results.

Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) reported quarterly losses of $(2.75) per share. This is a 49.45 percent increase over losses of $(5.44) per share from the same period last year.

Protagenic Therapeutics Q1 EPS $(2.75) Up From $(5.44) YoY

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

<h3>Gainers</h3>
<ul>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares rose 26.8% to $1.8 during Tuesday's after-market session. The company's market cap stands at $7.8 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock moved upwards by 17.85% to $0.2. The company's market cap stands at $5.1 million. </li>
<li>Aspire Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) shares moved upwards by 9.09% to $0.51. The company's market cap stands at $24.8 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) stock rose 9.03% to $0.59. The company's market cap stands at $3.5 million. </li>
<li>Radiopharm Theranostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) stock rose 7.69% to $4.2. The market value of their outstanding shares is at $32.6 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) shares rose 7.29% to $0.44. The company's market cap stands at $4.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares declined by 17.7% to $0.25 during Tuesday's after-market session. The market value of their outstanding shares is at $3.4 million. </li>
<li>Akari Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTX#NASDAQ">AKTX</a>) shares decreased by 16.43% to $1.17. The company's market cap stands at $33.7 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) stock declined by 8.38% to $0.2. The market value of their outstanding shares is at $1.4 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock decreased by 7.66% to $0.24. The company's market cap stands at $12.5 million. </li>
<li>BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) shares declined by 7.55% to $2.82. The market value of their outstanding shares is at $12.9 million. </li>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) stock declined by 7.37% to $0.02. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEON

AKTX

BCDA

CYCC

GCTK

LGMK

MNDR

NCNA

RADX

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares increased by 23.5% to $1.26 during Monday's after-market session. The company's market cap stands at $17.3 million. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock increased by 21.05% to $0.28. The company's market cap stands at $24.7 million. </li>
<li>Annovis Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) shares moved upwards by 8.08% to $1.46. The company's market cap stands at $28.4 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares rose 7.65% to $0.23. The company's market cap stands at $1.6 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) shares increased by 7.63% to $0.72. The market value of their outstanding shares is at $4.7 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares rose 7.03% to $0.24. The company's market cap stands at $1.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares declined by 15.7% to $3.49 during Monday's after-market session. The company's market cap stands at $53.1 million. </li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares decreased by 11.42% to $0.62. The company's market cap stands at $1.5 million. </li>
<li>Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) stock decreased by 10.04% to $260.0. The market value of their outstanding shares is at $7.9 billion. The company's, Q1 earnings came out today. </li>
<li>Precipio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) shares fell 9.19% to $5.24. The market value of their outstanding shares is at $7.7 million. </li>
<li>Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) shares declined by 7.57% to $1.1. The company's market cap stands at $2.7 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares declined by 6.8% to $0.41. The market value of their outstanding shares is at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADIL

ANVS

CLDI

ENVB

MEDP

PRPO

XAIR

YCBD

ZVSA

12 Health Care Stocks Moving In Monday's After-Market Session

Press Releases

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Legal

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Contracts

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

PTIX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Protagenic Therapeutics, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TXNM, SVT, INZY, PTIX on Behalf of Shareholders

Offerings

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, TXNM, SVT, PTIX on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders

Comments

Protagenic Therapeutics

Vendite allo scoperto

Protagenic Therapeutics (NASDAQ:PTIX) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO